At present, neurotoxic drugs targeting Aβ and tau proteins alone have not achieved significant efficacy, so a separate focus on the role of tau or Aβ in AD pathogenesis may not be entirely correct (Wilkins, 2023). The gene discussed is MAPT; the disease is Alzheimer disease.